Four things to know:
1. Medicrea specializes in artificial intelligence, predictive modeling and patient-specific implants.
2. The transaction bolsters Medtronic’s expansion into AI, machine learning and predictive analytics.
3. The company has more than 30 implants that have received CE Mark or FDA approval. The products are designed for spinal deformity and degenerative disc disease.
4. Terms of the transaction were not disclosed.
More articles on devices:
The most controversial trends in spine from 10 surgeons
Dr. Ali Baaj to build UArizona-Banner spine program from scratch in new role
Investment firm bets big on spine device company that rejected Stryker takeover
